NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

BowelScreen expects return to pre-pandemic capacity in 2023

By Paul Mulholland - 16th Apr 2023


BowelScreen expects to reach “pre-Covid” capacity by the end of this year, a spokesperson has said.

In 2022, 83.7 per cent of BowelScreen participants were offered a colonoscopy appointment within 20 working days of being deemed clinically suitable following pre-assessment. However, this was short of the 90 per cent target. Some 91.4 per cent of participants were offered an appointment within 30 days.

A total of 5,088 colonoscopies were completed in 2022, compared to 4,442 in 2021, 3,441 in 2020, and 4,807 in 2019.

During the year, BowelScreen invited over 303,000 people for screening, which exceeded the annual target. The screening programme is open to 60-to-69-year-olds. Anyone with symptoms is advised to contact their GP.

A priority focus has been the recovery of participation to pre-Covid 19 levels by maximising uptake among the eligible population through targeted communications and promotion.

“BowelScreen was significantly impacted by the changing Covid-19 environment and HSE cyberattack throughout 2021,” said the spokesperson. “Limited endoscopy capacity meant that screening invitations have been delayed by approximately a year. However, we expect to see a return to pre-Covid capacity by the end of 2023. Between December 2020 and 2022, we opened two new additional BowelScreen units – in Waterford and Mayo.”

The programme is working with hospitals to maximise colonoscopy capacity and examining ways to extend capacity.

Meanwhile, the Marie Keating Foundation has launched a new campaign to mark bowel cancer awareness month (April).

The #NoRegrets campaign, supported by Servier, encourages the public to be aware of the signs and symptoms of colorectal cancer and aims to raise awareness of the increasing incidence of early-onset disease.

Director of Nursing Services, Ms Helen Forristal, commented: “We run a Positive Living support group for those who are living with stage 4 or metastatic cancers and these groups support many men and women who are living with colorectal cancer. We have certainly seen a rise in the numbers attending our group with late-stage disease who are under 50. This campaign is so important because we want to increase awareness of the signs and symptoms and highlight to the public that no matter what your age, if you notice any of the symptoms or notice any changes, don’t dismiss them, get yourself checked.”

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read